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Background: Emerging evidence supports the view that (AQP) aquaporin water channels are regulators of trans-
cellularwater ﬂow. Consistent with their expression inmost tissues, AQPs are associatedwith diverse physiolog-
ical and pathophysiological processes.
Scope of review: AQP knockout studies suggest that the regulatory role of AQPs, rather than their action as passive
channels, is their critical function. Transport through all AQPs occurs by a common passive mechanism, but their
regulation and cellular distribution varies signiﬁcantly depending on cell and tissue type; the role of AQPs in cell
volume regulation (CVR) is particularly notable. This reviewexamines the regulatory role of AQPs in transcellular
waterﬂow, especially in CVR.We focus on key systems of the human body, encompassing processes as diverse as
urine concentration in the kidney to clearance of brain oedema.
Major conclusions: AQPs are crucial for the regulation of water homeostasis, providing selective pores for the
rapidmovement ofwater across diverse cellmembranes and playing regulatory roles in CVR. Gatingmechanisms
have been proposed for human AQPs, but have only been reported for plant andmicrobial AQPs. Consequently, it
is likely that the distribution and abundance of AQPs in a particular membrane is the determinant of membrane
water permeability and a regulator of transcellular water ﬂow.
General signiﬁcance: Elucidating the mechanisms that regulate transcellular water ﬂow will improve our under-
standing of the human body in health and disease. The central role of speciﬁc AQPs in regulating water homeo-
stasis will provide routes to a range of novel therapies. This article is part of a Special Issue entitled Aquaporins.© 2013 The Authors. Published by Elsevier B.V. All rights reserved.1. Introduction: Transcellularwater ﬂow: a regulatory role for human
1.1. Aquaporins
A striking property of most human tissues is their capacity for
extremely rapid ﬂuid transport. This is exempliﬁed by urine concentra-
tion in the kidney [1], the rapid formation of aﬂuid-ﬁlled cavity adjacent
to the oocyte during ovarian folliculogenesis [2] and secretion of saliva
from salivary glands [3]. These processes are essential to human health
and rely on the highly-regulated transport of water through tissues
[4,5]. Such trans-tissue water ﬂow is possible by two routes: transcellu-
lar water ﬂow across both basal and apical membranes, which occurs in
response to the osmotic stimuli [4] created by salt transport [6]; orerms of the Creative Commons
tribution, and reproduction in
credited.
ins.
r), r.m.bill@aston.ac.uk
lished by Elsevier B.V. All rights reserparacellular ﬂow across cell–cell junctions into intercellular spaces,
driven by salt or solute gradients [6]. Paracellular water ﬂow plays an
important role in leaky epithelia such as the corneal endothelium [7].
In this review, we focus on the regulatory role of aquaporin (AQP)
water channels in mediating transcellular water ﬂow across cell
membranes in the major systems of the human body (Fig. 1). The
study of the mechanisms of human AQP regulation that mediate
transcellular water ﬂow is still in its infancy and therefore this
review will also discuss mammalian AQPs as potential models for the
regulation of human AQPs (Table 1).
Transcellular water ﬂow is dependent on the permeability of the
plasma membrane to water molecules. Water movement by osmosis
may be through the lipid bilayer, by passive co-transport with other
ions and solutes [8] or through AQP water channels [9]. Many AQP
channels are thought to have an exquisite speciﬁcity for water and are
capable of rapidly transporting it in response to changes in tonicity;
evidence suggests that they make a critical contribution to the regula-
tion of transcellular water ﬂow [10].
Since theﬁrst AQPwas identiﬁed by Peter Agre in 1988 [11], thirteen
human AQPs have been discovered. Structural results for several family
members [12–14] have established that AQP channels share a commonved.
Fig. 1. Aquaporin expression in humans. The ﬁgure shows the wide distribution of AQP water channels throughout the human body. Organs are highlighted, starting at top right; within
each organ, the major AQPs involved in transcellular water ﬂow are denoted; a) Retina— AQP4, b) Olfactory epithelium— AQP4, c) The inner ear— AQP4 and AQP1, d) Brain— AQP4 in
astrocytes and AQP1 in choroid plexus, e) Spinal cord— AQP1, AQP4 and AQP8; Nucleus pulposus cells of the intervertebral disc— AQP1 and AQP3; Osteoclasts— AQP9, f) Blood vessels—
AQP1 in endothelial cells, g) Heart— AQP4, h) Kidney (showing the nephron in detail)— AQP1, AQP2, AQP3, AQP4 and AQP7, i) Salivary glands— AQP5, j) Gastrointestinal tract— AQP3,
AQP4, AQP5 and AQP9, k) Liver—AQP1, AQP8 and AQP9, l) Pancreas—AQP1 and AQP8,m) Lungs—AQP3, AQP4, AQP5, n) Fat (adipocytes)—AQP7; Skin—AQP1, AQP3, AQP5 andAQP10,
o) Female reproductive tract— AQP7, AQP8 and AQP9 in ovaries, and p) Male reproductive system — AQP3 and AQP7 in sperm cells.
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Table 1
Tissue distribution and roles of AQPs in transcellular water ﬂow. AQPs discussed in this review are presented in terms of their localisation and regulatory roles in transcellular water ﬂow within organ tissues.
System AQP protein localisation Role of aquaporins in transcellular water ﬂow References
Nervous Retina — AQP4 Suggested role in Muller cell water balance. [64]
Olfactory epithelium — AQP4 Membrane permeability - link to olfaction. [65]
Inner ear — AQP4 (hensons, claudius and Inner Succlus cells), AQP1 (ﬁbrocytes) AQP4 mediated transcellular water ﬂow in to Henson cells exiting via AQP4 on basal membrane of Claudius cells [66]
Brain — AQP4 astrocytes, AQP1 (choroid plexus) AQP4 at astrocyte end feet for BBB water permeability. AQP1 secretion of CSF, AQP4 absorption of CSF [62,47]
Spinal cord — AQP1, AQP4, AQP8 Localisation of AQPs suggests transcellular water ﬂow from perivascular space to interstitium, into central canal [54]
Renal (kidney) Proximal tubule — AQP1 (apical and basolateral),
AQP7 (apical of convoluted and straight)
Water reabsorption, importance of AQP7 unknown [9,69]
Renal collecting duct cells — AQP2 (apical, sub apical vesicles),
AQP3 and AQP4 (basolateral)
Urine concentration by AQP2 AVP mediated water absorption - AQP3 and 4 exit pathways into blood [63,68]
Descending thin limb of henle — AQP1 Water reabsorption [9]
Descending vasa recta — AQP1 Water reabsorption [9]
Connecting tubule — AQP3 Water homeostasis [9]
Integumentary Skin — AQP1 (endothelia of dermis), AQP3+10 (keratinocytes of epidermis),
AQP5 (sweat glands)
Homeostasis, glycerol or water transport for skin hydration, sweat excretion [96–98]
Fat — AQP7 (adipocytes) Glycerol transport [102]
Cardiovascular Blood vessels — AQP1 strongly expressed in endothelia outside of brain i.e. Airspace-Capillary osmotic water permeability and heart vasculature [112]
Cardiomyocytes — AQP4 Absorption of excess water from interstitial space into to capillaries [113]
Respiratory Lung alveolar epithelium — AQP5 (apical membrane) Transcellular water ﬂow route for water absorption and secretion in airway, Role in airway hydration [117]
Airway epithelial lining — AQP3 and AQP4 Possibly provide route for water into capillaries of airway [87]
Airway sub-mucosal glands — AQP5 (apical membrane) Fluid secretions into lumen of submusosal glands for mucous production and hydration [119]
Reproductive Ovarian granulosa cells — AQP7, AQP8, AQP9 Transcellular water ﬂow in folliculogenesis [2]
Epididymis Transepithelial water transport and sperm concentration [129,135,137,138]
Sperm — AQP3, AQP7 CVR to prevent swelling and to aid mobility [41]
Digestive Salivary Glands — AQP5 (acinar cells, intercalated duct cells),
AQP8 (myoepithelial cells)
Transcellular water transfer in process of primary saliva secretion [87,147]
Oesophagus — AQP3 (stratiﬁed epithelia) Intracellular osmolarity and CVR to water deprived cells [143]
Stomach — AQP3 (stratiﬁed epithelia), AQP4 (BLM parietal cells),
AQP5 (pyloric gland)
Provide water to cells facing harsh conditions, AQP4 - gastric acid secretion,
AQP5 transcellular water secretion for mucous production
[141,143,144]
Small intestine — AQP4, AQP9 (goblet cells) Transcellular colonic ﬂuid transport, AQP9 aids in mucous secretion [149]
Colon — AQP3 (simple+ stratiﬁed epithelia of distal colon),
AQP4 (surface epithelia)
Water absorption from intestine and colonic ﬂuid transport [144,149]
Liver — AQP1 (cholangiocytes), AQP8 (hepatocytes),
AQP9 (sinusoidol membrane of hepatocyte)
AQP8 — osmotic driven water transfer and homeostasis, AQP9 — glycerol uptake from blood released by AQP7 [82,152]
Pancreas — AQP1 (inter/intralobular ducts), AQP8 (acinar cells) AQP1 — Transcellular water transfer and pancreatic juice secretion, AQP8 — Pancreatic juice secretion [146]
Musculoskeletal Muscle ﬁbres — AQP4 Contraction-induced muscle swelling
Articular cartilage — AQP1, AQP3 Involved in cell swelling during mechanistic load [160]
Intervertebral disc — AQP1, AQP3 (nucleus pulposus cells) AQP1 and 3 involved in NP cell swelling during mechanistic load [159]
Osteoclasts — AQP9 AQP9 osteoclast differentiation and cell fusion — increase in cell volume [154,156]
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structural data [15] have revealed that the functional AQP unit is a
homotetramer [15] and that each AQP monomer is composed of six
transmembrane (TM) α-helices connected by alternating intracellular
(ICL) and extracellular (ECL) loops. The TM domains form a right-
handed bundle around the central pore of each AQP monomer through
which water transport occurs [16]. The speciﬁcity of the pore for water
is a result of direct hydrogen bonding, in a pairwise manner, between a
single ﬁle of water molecules and the AQP family's signature Asn-Pro-
Ala motif at the narrowest part of the pore [16]. Water selectivity is
further aided by interactions with the aromatic/arginine constriction
site, which physically restricts the pore [16]. While the structural bio-
logy of the AQP family is therefore widely accepted, the mechanisms
that regulate the physiological function of AQPs are lesswell established
[17].
AQPs are expressed in a wide range of tissues (Fig. 1), often spatially
located within a certain region of the cell. This enables them to play a
central role in the ﬂow of water through those tissues, which typically
triggers cell volume regulation (CVR) mechanisms. Whilst transport
through all AQPs utilises a commonpassivemechanism, their regulation
and cellular distribution varies signiﬁcantly between systems, speciﬁ-
cally in constituent tissues and cells [17]. This review examines the
regulation of transcellular water ﬂow in the human body by AQP
channels with a particular focus on CVR.
2. Transcellular water ﬂow and cell volume regulation
CVR is a necessary mechanistic component of AQP-mediated trans-
cellular water ﬂow (Fig. 2). It comprises regulatory volume decrease
(RVD), usually in response to hypotonicity-induced cell swelling, and
regulatory volume increase (RVI), usually in response to hypertonicity-
induced cell shrinkage. The molecular mechanisms underlying these
responses are not yet fully understood, but it is unlikely that there is aKCC
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Fig. 2. Solute transport pathways mediating CVR (A) regulatory volume decrease and (B) reg
through the cell membrane depending on the cellular AQP isoforms and expression levels. KC
VRAC: volume regulated anion channel; NSCC: non-selective cation channel.single common mechanism [18]. The signalling pathways associated
with CVR appear to be cell-type dependent [18]. Nonetheless, the end
results of these varied pathways are similar: RVD relies on osmolyte
(potassium chloride and taurine [19]) and water efﬂux from the cell to
reduce cell volume whereas RVI is achieved by osmolyte and associated
water inﬂux via import of sodium to the cell. Although the rapid RVI
process following cell shrinkage involves inorganic ions, after hours of
prolonged hypertonic exposure, animal cells often replace the ions
with non-perturbing organic osmolytes. Themechanisms for this include
external transport into the cell, down-regulation of organic degradation
and up-regulation of organic synthesis [20]. These mechanisms facilitate
the homeostasis of osmolality within the cell.
2.1. Regulatory volume decrease
In RVD (Fig. 2), the activation of K+ channels allows efﬂux of K+
from the cell and subsequent water loss by osmosis either through
AQPs or directly through the lipid bilayer; biophysical data show that
AQP expression can increase membrane water permeability by up to
~50 fold [21,22]. This K+ efﬂux can be either dependent on intracellular
calcium concentration [Ca2+] (e.g. in human cervical cancer cells [23])
or [Ca2+]i independent (e.g. in Ehrlich ascites tumour cells [24]). In
most cell types an intact actin cytoskeleton is necessary for
hypotonicity-induced K+ efﬂux. However, in trigeminal ganglion
neurons, cytochalasin D (an actin polymerisation inhibitor) treatment
stimulated swelling activation of a K+ current [25] demonstrating that
in these cells an intact actin network not only is unnecessary for RVD,
but also appears to be inhibitory. In some cells, protein kinase C (PKC)
activation has also been shown to induce an outward K+ current via
the same channels that are activated in RVD [26]. Movement of K+
out of the cell is favoured by the concentration gradient but to maintain
the electrostatic membrane potential, volume-regulated anion chan-
nel(s) (VRAC) simultaneously move anions (mainly Cl− during RVD)Taurine
efflux 
pathway
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ulatory volume increase. Water movement by osmosis may be through AQPs or directly
C: potassium chlorine co-transporter; NKCC: sodium potassium chlorine co-transporter;
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thought that four K+-Cl− co-transporters (KCCs), known to be activated
by cell swelling, may be involved [29,30].
2.2. Regulatory volume increase
In RVI (Fig. 2), the activation of Na+-H+ exchangers and Na+-K+-
2Cl− co-transporters (NKCCs) causes cellular inﬂux of Na+ and subse-
quent volume increase by osmotic movement of water [18]. The
Na+-H+ exchange pump, NHE1, is known to be activated by cell
shrinkage [31], which may be mediated by binding of calmodulin to its
carboxy-terminus [32]. The co-transporter, NKCC1, is known to be
activated by cell shrinkage, potentially through lysine-deﬁcient protein
kinase 1 (WNK1) and proline/alanine-rich protein kinase (SPAK) signal-
ling [33]. Amiloride-sensitive non-selective cation channels (NSCCs)
may also play a role [34].
2.3. The regulatory role of aquaporins
The water permeability of cell membranes may not be the rate-
limiting factor in CVR [35], but any rapid change in cell volume is likely
to involve AQPs. For example, the stretch-activated transient receptor
potential vanilloid type 4 (TRPV4) channel is a Ca2+-biased NSCC that
is activated by cell swelling [36] and has been implicated in osmosensing
[37]. In some cell types TRPV4 has been shown to provide a Ca2+ signal
that is correlated with activation of the K+ and Cl− channels responsible
for the decrease in cellular osmolality associated with RVD [38,39]. In
human and murine salivary gland cells, TRPV4 has a functional interac-
tion with AQP5: in AQP5 knockout cells, the hypotonicity-induced
calcium inﬂux through TRPV4 was attenuated and subsequent RVD
was abolished. Hypotonicity also increased cell surface expression of
both TRPV4 and AQP5 and increased their co-localisation [40].
In another example, the sperm of AQP3−/−mice did not undergo
their normal RVD process and the mice displayed reduced fertility
[41,42]. Upon entry into the female reproductive tract, sperms normally
encounter a decrease in extracellular osmolality, which is thought to be
the signal that activates sperm motility [41]. However, this hypotonic
stress also causes cell swelling which, if left uncorrected by RVD, leads
to impaired fertilisation caused by excessive bending of the sperm tail
inside the uterus [42]. If AQP3 was simply acting passively as a water
channel, RVD would not be abolished in AQP3 −/− mice but rather
the timescale on which the cell reaches osmotic equilibrium would be
increased. One explanation for reduced fertility and altered RVD in
AQP3 −/− mice is therefore that AQP3, either alone or as part of a
macromolecular complex, is involved in the signalling pathway that
activates RVD in sperm.
When exposed to a hypotonic extracellular solution, cultured renal
cortical collecting duct (renal CCD) cells, which do not endogenously
express AQP2, swell in proportion to the change in extracellular osmo-
lality but do not exhibit RVD. However, when they are transfected
with AQP2, these cells show an RVD of approximately 40%. Shrinkage
is mediated by Ca2+ inﬂux through TRPV4, which activates Ca2+-
dependent K+ and Cl− channels and Ca2+-dependent Ca2+ release
from intracellular stores. In renal CCD cells expressing AQP2, hypotonic
stress causes translocation of TRPV4 to the plasma membrane, which is
absent in AQP2-negative cells. When TRPV4 was translocated to the
cell surface prior to hypotonic exposure using 4α-phorbol 12,13-
didecanoate, RVD was recovered in AQP2-null cells, showing that it is
not simply the high water permeability of AQP2 that allows RVD. How-
ever, there does not appear to be any co-localisation between endoge-
nous TRPV4 and overexpressed AQP2 in this system, either before
or after hypotonic shock, indicating a functional rather than physical
interaction [43]. These observations suggest that AQP2 (and therefore
possibly other members of the AQP family) forms part of a sensory
and signalling pathway that results in TRPV4 translocation, possibly
via sensing of extracellular osmolality.Taken together, these examples support the idea of a signalling or
sensory role for AQPs in RVD mechanisms. We have been unable to
ﬁnd any evidence of AQPs playing similar roles in RVI. However, given
that a variety of AQPs could be involved in the RVD mechanism and
that RVI and RVD share a common basic mechanism involving the
movement of osmolytes to elicit a volume change, it would not be
surprising to discover a link between RVI and AQPs that goes beyond a
passive water conduction mechanism.
3. Regulation of transcellular water ﬂow in the human body
3.1. The brain and nervous system
3.1.1. Localisation of AQPs
AQPs are widely expressed in the central nervous system (CNS);
indeed, more studies have been conducted on AQPs in the CNS than
on AQPs in the peripheral and enteric nervous systems (for a detailed
review on AQPs in the nervous system see Papadopoulos et al. [44]).
The major AQPs found in the CNS are (i) AQP4 in the glia [45] and
neurons [46], (ii) AQP1 in the epithelia of the choroid plexus (which
forms the cerebrospinal ﬂuid (CSF)–brain barrier) [47], dorsal root
ganglia [48] and oesophageal neurons [49] and (iii) AQP9 in the
substantia nigra [50]. Glial cells are not nerve cells but are essential for
regulation and homeostasis of the CNS and comprise approximately
90% of cells in the brain [51]. Astrocytes are the most abundant glial
cells within the brain [51] and high levels of AQP4 are expressed in
their plasma membranes. The distribution of AQP4 is highly polarised
to the astrocytic end feet, which contact the blood vessels associated
with the blood–brain and brain–ﬂuid interfaces [81]. The astrocytic
end feet therefore function as part of the blood–brain-barrier (BBB)
water exchange mechanism; this has been established to be AQP4
dependent since deletion of AQP4 in mice resulted in a 31% decrease
in brain water uptake measured using the wet/dry mass method to
determine brain water content [52].
3.1.2. Regulatory role of AQPs
As themain AQP of the CNS, AQP4 is expected to play amajor role in
the regulation of water ﬂow in the brain, spinal cord [53,54] and inter-
stitial ﬂuid surrounding neurons, thereby maintaining the K+ concen-
trations required for neuroexcitation [46,55]. In support of this, when
AQP4 was silenced in astrocytes by RNA interference, the apparent
diffusion coefﬁcient (which is a measure of water movement within
tissues, determined by magnetic resonance imaging) was decreased
by 50% in rat brain [56]. It is in this context that low AQP4 expression
levels have been associated with epileptic seizures [55].
There is evidence that AQP translocation occurs in astrocytes, which
may be responsible for the regulation of AQP abundance in the plasma
membrane [57]. Although AQP4 is primarily expressed at the plasma
membrane, its surface abundance is increased by AQP4-carrying vesi-
cles in response to hypotonic stimuli in cultured rat cortical astrocytes:
a positive correlation between vesicle mobility and AQP4 density at the
plasma membrane was observed [58]. As well as AQP4, the stretch-
activated TRPV4 channel is also strongly expressed in astrocytic end
feet [59]. It has been suggested that AQP4 and TRPV4 are co-expressed
and form a molecular complex, interacting at the plasma membrane
to control CVR in astrocytes. When mouse primary astrocytes were
put under hypotonic stress, an increase in intracellular Ca2+was follow-
ed by an RVD response; this mechanism failed in cells deﬁcient in AQP4
and in cells where RNA interference was used to silence TRPV4, even
if they were transfected with AQP1 [59,60]. This suggests that RVD in
astrocytes may be AQP4/TRPV4 speciﬁc, although the swelling of
AQP1-expressing cells in this study was not as marked as for AQP4-
expressing cells. Therefore, if total cell volume is the biophysical quanti-
ty being detected during the RVD response, it is possible that the loss of
RVD simply reﬂects the fact that a volume threshold has not beenmet. If
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between AQP2 and TRPV4 in renal cells [43], discussed above.
AQP4 has been largely associated with the pathophysiology of brain
oedema [61] of which there are two major types: vasogenic oedema is
the accumulation of water in the extracellular space, usually due to
impaired function of the BBB; cytotoxic oedema is the swelling of
astrocytes whilst maintaining their cellular integrity [44]. Movement
of water from the blood across endothelia into astrocytes is mediated
by AQP4 channels; reduced cytotoxic oedema was seen in AQP4 −/−
mice [62]. AQP4 is also thought to mediate the reabsorption of excess
ﬂuid in vasogenic brain oedema by transcellular movement of ﬂuid
from the extracellular space at the astrocytic end feet to the vascular
and ventricular regions of the brain through the endothelial and epithe-
lial barriers. In support of this, AQP4 null mice show an increase in brain
water accumulation due to the reduction of transcellular water transfer
to blood or CSF [61].
AQP1 expression is restricted to the choroid plexus region of the
brain under normal conditions [47], but it is expressed in microvascular
endothelia and reactive astrocytes of brain tumours where it is thought
to play a role in the development of vasogenic oedema [63].
Osmotically-induced water transport was reduced 5-fold in AQP1 null
mice along with a decrease in intracranial pressure and a 25% decrease
in CSF production [47]. The same group also investigated the expression
and localisation of AQPs in mouse spinal cord, an area that has not been
the focus ofmany studies. Expression of AQP4was detected in the astro-
cytic end feet of the grey matter in contact with capillaries and the
ﬁbrous glial processes of the white matter, again surrounding the
blood vessels. The distribution of several other AQPs throughout the
spinal cord suggests a role inmaintenance ofwater balance via transcel-
lular water ﬂow; ﬂuid moves rapidly from the spinal subarachnoid
space into the perivascular space and across the interstitium into the
central canal. This rapid water movement may be mediated by AQP4
and AQP9 in the glia limitans and AQP8 across the ependymal layer
into the central canal [54].
In addition to its localisation in astrocytes, AQP4 is also expressed in
the retina [64], the olfactory epithelium [65] and within Claudius' and
Henson's cells of the inner ear [66]. Large K+ ﬂuxes trigger an AQP4-
mediated transcellular water inﬂux that exits via AQP4 channels local-
ised on the basal membrane of Claudius' cells [66]; AQP4 involvement
in CVR may be an important mechanistic component of acoustic signal
transduction since AQP4 null mice are completely deaf but have no
alterations to the morphology of the inner ear [66].
3.1.3. Conclusions
Transcellular water ﬂow within the brain is largely associated with
the formation and clearance of oedema; the highly-polarised distribu-
tion of AQP4 at the end feet of astrocytes is key in the absorption of
excess vasogenic ﬂuid for clearance by the capillaries into the blood-
stream. However, AQP4 may have an additive effect on water accumu-
lation in cytotoxic oedema as summarised in Fig. 3. The positioning of
AQP1 along the epithelial barrier of the CSF-containing choroid plexus
indicates a role in supplying water for CSF via a transcellular route. It
is also evident that AQPs play an important role in signalling throughout
the nervous system's peripheral and sensory organs by their contribu-
tion to CVR mechanisms and K+ concentration maintenance. Under-
standing these mechanisms will be essential in developing treatments
for brain oedema following stroke, trauma and meningitis.
3.2. The renal system
3.2.1. Localisation of AQPs
The role of AQPs in the kidney is one of themost extensively studied
areas in AQP research [67]. The kidney is the major site of arginine vaso-
pressin — (AVP; also called anti-diuretic hormone or ADH) mediated
body water homeostasis; in response to osmotic stimuli, water
reabsorption occurs throughAQP channels enabling urine concentration.AQPs in the kidney exhibit a highly-polarised and speciﬁc localisation
pattern (Fig. 1): AQP1 is expressed in proximal tubule (PT) cells; AQP2
is very prominent in the renal collecting duct (renal CD) principal cells
and is found at the apical plasma membrane [68] and in sub-apical
vesicles [1]; AQP3 and AQP4 are expressed in renal CD cells at the
basolateral membrane [69,70]. AQP1 is responsible for most water
reabsorption in the kidney [71] while AQP2 ﬁne tunes water re-
absorption; it is translocated within the sub-apical vesicles to the apical
membrane after AVP activation, increasingmembranewater permeabil-
ity [1]. Once water has entered a renal CD cell, AQP3 and AQP4 provide
exit routes to the blood [72].
3.2.2. Regulatory role of AQPs
AQP2/AVP-activated translocation is induced by a well-studied pro-
tein kinase A (PKA)-dependent pathway [73]. Upon recognition of an
osmotic stimulus, AVP is released and subsequently binds the G
protein-coupled receptor (GPCR), vasopressin V2 receptor (V2R), on
the basolateral membrane of renal CD principal cells. This results in G
protein activation of PKA and subsequent phosphorylation of AQP2 at
Ser266 within intracellular vesicles; this facilitates vesicle translocation
along the microtubule networks to the apical membrane [74] (Fig. 3A,
B). The critical role of this mechanism in the ﬁne control of water
reabsorption is exempliﬁed by its dysfunction in nephrogenic diabetes
insipidus; in this disease, mutations in the vasopressin 2 receptor or in
AQP2 itself lead to a decreased ability to concentrate urine [75].
An intracellular Ca2+ inﬂux is needed to generate the necessary RVD
response following hypotonic exposure; in the distal kidney, this only
occurs in the presence of AQP2 [76]. A functional interaction between
the Ca2+-permeable TRPV4 ion channel and AQP2 has been demon-
strated to occur under hypotonic conditions in renal CD cells and is
involved in RVD. Notably, the TRPV4 channel is only activated in cells
that express AQP2. When TRPV4 is blocked by ruthenium red, Ca2+
entry is abolished alongwith RVD. This conﬁrms AQP2 and TRPV4 as es-
sential components of the hypotonicity-induced RVD cellular response
[43]. It has also been shown that AQP2 can regulate CVR by interacting
with tropomyosin 5b (TM5b) and altering the dynamics of the cytoskel-
eton. Ser256 phosphorylation induces an AQP2-TM5b interaction lead-
ing to depolymerisation of actin ﬁlaments; this mechanism is reversible
[77].
AQP2 is also regulated independently of AVP in response to hyper-
tonic conditions. Hypertonic exposure (600 mOsM/kg) was shown to
signiﬁcantly increase activity of the AQP2 promoter, independent of
AVP, in MDCK cells expressing murine AQP2. The responsive element
was suggested to reside between−6.1 and−4.3 kb 5′ ﬂanking region
of the AQP2 gene [78]. Acute hypotonicity has also been shown to
induce translocation of AQP2 to the plasma membrane in the absence
of AVP: rapid plasmamembrane and trans-Golgi network accumulation
of AQP2 in rat renal CD cells were shown to be dependent onMAPK, P38
and ERK1/2 activity [79].
Early reports suggested that AQP1 was constitutively expressed in
PT cell membranes in the kidney [80], however recent studies have
shown that AQP1 is expressed in both the cytoplasm and in the mem-
brane of cultured cells and can be induced to undergo rapid and revers-
ible translocation to the plasmamembrane upon hypotonic stimulation
mediated by TRP channels, calcium, PKC and microtubules [57,81].
AQP1 has also been shown to undergo translocation to the plasma
membrane of cholangiocytes in response to secretin activation of specif-
ic G protein-coupled receptors [82]. Further studies have demonstrated
that the diuretic effect of acetazolamide involves triggered AQP1
translocation by promoting AQP1 and myosin heavy chain interactions
causing AQP1 localisation to proximal tubule cell membranes followed
by ubiquitin-mediated AQP1 degradation through the proteasome
[83]. AQP2 ubiquitination has also been shown to be involved in AQP2
expression and localisation [84]. Phosphorylation of AQP1 has been
shown to be involved in translocation of AQP1 to the plasmamembrane
in oocytes [85].
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Kidney AQPs form a highly-organised network that facilitates the
maintenance of water homeostasis. The speciﬁc localisation of AQPs
within renal CD cells provides a transcellular pathway for water to be
reabsorbed from the urine through AQP2 channels into renal CD cells
and back into the blood via AQP3 and AQP4 on basolateral membranes.
The regulation of AQP1 expression and translocationmediates transcel-
lular water ﬂow in PT cells [83].
3.3. Specialised secretory tissues
3.3.1. Localisation and regulatory roles of AQPs
Specialised secretory tissues rely on AQP-dependent transcellular
water ﬂow to facilitate their ﬂuid homeostasis. In the salivary gland,
AQP5 facilitates transcellular water ﬂow in both acinar and parotid sal-
ivary cells [86]; the salivary cells isolated fromAQP5−/−mice had dra-
matically reducedmembranewater permeability following exposure to
hypertonic or hypotonic conditions [3]. The localisation of AQP5 on the
luminal membrane is consistent with the membrane's high water per-
meability and its role in osmotic water transport from the acinar cells
to the lumen of the gland used in the production of saliva [87,88].Immunohistochemistry of human salivary glands (HSG) has demon-
strated that AQP3 is present on the basolateral membranes of mucous
and serous acinar cells [89], indicating a possible role for AQP3 as well
as AQP5 in transcellular water ﬂow during saliva formation [89].
In HSG, AQP5 translocation was shown to occur in a microtubule-
dependentmanner; elevation of [Ca2+]i by stimulationwith thapsigargin
(a Ca2+-ATPase inhibitor) and a Ca2+ ionophore resulted in AQP5
localisation at the plasma membrane, which was inhibited by pre-
treatment with the microtubule inhibitors, colchicine and vinblastine
[90]. GFP-tagged human AQP5 has been shown to translocate to the
plasma membrane of HSG cells upon stimulation with carbachol
(a muscarinic type 3 receptor (M3R) agonist) [91], but little is known
about the molecular mechanisms involved.
AQP5 translocation to the apical membrane of rat parotid gland cells
has been shown to occur following stimulation of M3R with acetylcho-
line (ACh) and subsequent [Ca2+]i elevation. Furthermore, following in-
cubation with a Ca2+ ionophore translocation was activated without
ACh stimulation [92]. Increased levels of AQP5 mRNA and protein
were observed when rat submandibular acinar cell lines were exposed
to hypotonic conditions causing rapid cell swelling and more efﬁcient
RVD. EGTA chelation of intracellular and extracellular Ca2+ did not
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Cl−-dependent, with mitogen-activated ERK-activating kinase (MEK)
and the β-amino acid, taurine, playing important roles [93].
Increasing [Ca2+]i has been shown to trigger AQP5 translocation
from cytosolic compartments to the plasma membrane while the
removal of extracellular Ca2+ has been shown to inhibit translocation
of AQP1 in HEK293 cells [57]. Acinar cells from mice lacking the
TRPV4 channel or AQP5 display reduced hypotonicity-induced Ca2+
inﬂux and a suppressed RVD response suggesting an important role
for TRPV4 and AQP5 interactions in generating the Ca2+ response
required for effective RVD after hypotonic cell stress [40]. There is little
knowledge on the regulation of AQP5 in sweat glands. Eccrine sweat
glands have a high water permeability to support their role in ﬂuid
secretion; primary sweat is deposited into the lumen of the eccrine
gland before water movements allow sweat to be secreted through
the ductal region [94]. Recently, AQP5 has been shown to be expressed
in apical membranes, intracellular canaliculi of secretory coils and in
basolateral membranes of human eccrine sweat glands. Rapid apical
translocation of human AQP5 occurs in stably-transfected MDCK cells
after treatment with the Ca2+ ionophore, A23187, suggesting the
involvement of [Ca2+]i in AQP5 translocation. Rapid translocation of
AQP5 to the apical plasma membrane of cells has also been shown in
mouse sweat glands during sweating [95]. In humans, ACh activation
of muscarinic receptors raises [Ca2+]i and induces sweating [94]. It is
thought that AQP5 regulation by [Ca2+]i contributes to sweat release
by increasing apical membrane permeability, and that AQP5 may co-
localise with the Ca2+ channel, ANO1, at the plasma membrane [95].
However, the mechanisms behind AQP5 translocation within the
sweat gland, including the role of phosphorylation, still require further
elucidation.
3.3.2. Conclusions
AQP5 is involved in regulating transcellular water ﬂow in the luminal
regions of glands. This facilitates the formation of secretions at the
necessary concentrations and viscosities required to maintain water
homeostasis.
3.4. The integumentary system
3.4.1. Localisation and regulatory roles of AQPs
The integumentary system comprises the skin, hair and nails, but
nerves, certain glands and fat are often also classiﬁed as parts of the
integument. The skin plays an integral part in water homeostasis and
provides a barrier function against excessive water loss. Its water and
glycerol content is essential for normal function; this is largely under
the control of AQP3, which is expressed mainly in the plasma
membranes of the stratum basale of the epidermis, with decreasing
expression towards the stratum granulosum and none in the stratum
corneum [96]. Sugiyama and colleagues [97] ﬁrst reported expression
of AQPs 3 and 9 in human cultured keratinocytes, although AQP9 was
only observed in differentiating cells. AQP3-null mice display impaired
barrier function and reduced stratum corneum hydration, which was
not corrected by skin occlusion or exposure to high humidity. However,
topical or oral administration of glycerol has shown to correct many
defective skin functions in AQP3-null mice [98].
AQP1 has been detected in skin biopsies in a study of atopic eczema,
although its expression was no different in diseased or control skin,
whereas up-regulation of AQP3 was found [99]. Skin diseases that
show reduced stratum corneum hydration display altered expression
levels of AQP3, dependent upon the disease. In 2011, Voss and
colleagues showed that in psoriatic skin, AQP3 was preferentially
expressed in the cytoplasm rather than the plasmamembrane suggest-
ing that AQP3 may be important for transcellular water and glycerol
transport. AQP5 is also thought to be expressed at the plasma
membrane in the stratum granulosum and may play a role in trans-
cellular water homeostasis in the skin [100].AQP7 is the primary glycerol transporter inwhite (WAT) and brown
(BAT) adipose tissues. AQP7 is abundantly expressed in the plasma
membrane of adipocytes and fasting has been shown to up-regulate
AQP7 mRNA in the adipocytes of rodents [101]. In the model mouse
adipocyte cell line, 3T3-L1, increases in AQP7 mRNA expression and
glycerol release were correlated during cell differentiation indicating
that plasmamembrane glycerol permeabilitymaymediate the accumu-
lation of fat in adipocytes [102]. AQP3 and 9 are also expressed in
human adipose tissue, with AQP3 predominantly localised in the
cytoplasm and AQP9 constitutively expressed in the plasmamembrane;
a positive correlation between the transcript levels of AQPs 3, 7 and 9
and body weight (BMI) has been suggested [103]. AQP7 gene expres-
sion is down-regulated in the WAT of obese human subjects compared
with normal controls [104,105], but unchanged in type 2 diabetes [104].
However, the link between human AQPs and obesity is contradictory; a
review by Maeda et al. [106] describes some of these studies. More
recently AQP10 has been proposed to be an alternative pathway for
glycerol efﬂux in human adipocytes [107].
3.4.2. Conclusions
AQP3, 7, 9 and 10 are aquaglyceroporins. It is therefore likely that the
roles of these AQPs in the integumentary system primarily involve
transport of glycerol, although they may also be involved in the regula-
tion of transcellular water ﬂow; this remains to be determined.
3.5. The cardiovascular system
3.5.1. Localisation and regulatory roles of AQPs
Cardiac AQPs have not been investigated to the same extent as AQPs
in the brain and kidney. In the heart, water moves from the interstitial
space, across endothelia and into blood vessels. This process is typically
attributed to paracellular water transport through the endothelium of
the heart since it is considered to be ‘leaky’ compared to the endotheli-
um of other organs [108]. Myocardial stunning is the reduced output of
the heart, often seen following cardiac surgery such as heart bypass, and
has been associated with cell swelling and oedema. The expression of
members of the AQP family in the myocardium has been poorly
characterised and their role, if any, in the pathology and resolution of
cardiomyocyte swelling, oedema and general function within the
heart has not been investigated (for a detailed review on AQPs and
myocardial water management see Egan [109]).
AQP1 has been detected in the human, rat and mouse heart tissue
[110], while AQP4 has only been detected in themouse heart [110]. Im-
munoﬂuorescence images revealed that the abundantly-expressed
AQP1 is distributed in human and murine cardiac microvasculature at
high levels only because of the dense vascularity of the heart muscle
[110]. Immunoﬂuorescence also showed that AQP4 was localised in
theplasmamembranes of the cardiomyocytes of themouse heart tissue.
Functional studies on cardiac membrane vesicles from AQP1 and AQP4
knockout mice found that only AQP1 had a role in water permeability
in the heart; vesicles from AQP1-null mice had reduced permeability
but deletion of AQP4 produced no reduction in water permeability
[110]. A study using rabbit ventricular cardiomyocytes suggested that
water movement in the heart is mediated by paracellular water ﬂow
and does not occur via AQPs [111]. On the rare occasion that an osmotic
gradient is present in the heart (e.g. during cell swelling after cardiac
surgery), endothelial AQP1 might mediate the ﬂow of water from the
expanded interstitial space into the capillaries [112]; indeed AQP1 is
the major AQP expressed in vascular endothelial cells [113].
There is controversy over the details of AQP4 expression in the
human heart; some studies have reported mRNA expression but no or
very little protein [110]. However, a recent study [114] demonstrated
the presence of AQP4 protein in the human heart using Western
blotting; it was localised to the plasma membrane with a very weak
signal in the cytosol. Immunoblot analyses of cultured mouse cardio-
myocytes also showed that AQP4 was present while immuno-gold
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brane of the cardiomyocytes. Cardiac oedema arises when tissue with a
reduced blood supply (ischemic) becomes hypertonic, causing water to
ﬂow from the capillaries (possibly via AQP1) into cardiomyocytes; this
causes cell swelling and reduced cardiac output. Ischemic mice had a
decrease in AQP4 mRNA, as measured by RT-PCR. AQP4 knockout mice
presented with lower cardiac ischemic injury, measured as infarction,
suggesting that AQP4may be a possible target for treatment of myocar-
dial infarction.
3.5.2. Conclusions
The major AQP of the cardiovascular system is AQP1 (Fig. 1), which
probably regulates water permeability of the heart's capillary networks
by mediating the ﬂow of water through the endothelial layer into the
blood. AQP1may aid the absorption of excesswater from the interstitial
space into the capillaries, however this is controversial. Further research
is therefore required on the role of AQPs in the heart; thismight provide
evidence for AQP1 and/or AQP4 as drug targets for the treatment of
myocardial stunning oedema within the interstitium. AQP4 has only
recently been detected at the protein level within human cardio-
myocytes, which could lead to research into AQPs as transcellular
water transporters for clearance and formation of interstitial oedema
and cardiomyocyte swelling.
3.6. The airway
3.6.1. Localisation of AQPs
Airway hydration, sub-mucosal secretions and alveolar ﬂuid trans-
port all require water permeability of the epithelial and endothelial
membranes of the airway [115]. AQPs are consequently expressed in
bronchopulmonary tissues (Fig. 1) and are regulated in a way that facil-
itates transcellular water transport [116,117]. AQP1 is expressed
predominantly in the microvascular endothelia throughout the lung
and upper airways [117], while AQP3 and AQP4 are present in the
basolateral membranes of the airways' epithelial lining [88]. AQP5 is
expressed in the apical membrane of type I alveolar epithelial cells of
the distal lung and acinar sub-epithelial glandular cells, which provides
the major route (along with AQP1) for the osmotically driven ﬂow of
water within the entire airway system [118]. AQP5 is also expressed
superﬁcial epithelium of the bronchus and, as such, is ideally placed to
regulate the hydration of the airway surfaces [119]. Indeed, studies
with knockout mice have shown that AQP5 enhances ﬂuid secretion
[120]. In addition, AQP5 expression is reduced in inﬂammatory airway
conditions, such as chronic obstructive pulmonary disease (COPD),
that associate with mucus hypersecretion [119]. Modulation of AQP5
expression could therefore serve as therapy for inﬂammatory airway
conditions, alleviating symptoms such as the increase in desiccated
mucuswhich potentiates the chronic airways infections typical of cystic
ﬁbrosis [121].
3.6.2. Regulatory role of AQPs
When AQP expressionwithin the airwaywasﬁrst discovered, sever-
al murine AQP knockout studies were published that investigated the
hypothesis that water can be transported from the alveolar airspace
across the interstitial and capillary compartments via osmotically-
driven AQP transport. Initially, osmotic water permeability (Pf) of the
lungs was measured in AQP1 and AQP4 knockout mice; Pf was reduced
by 10-fold in the endothelia of AQP1 nullmice suggesting a transcellular
route. However, it was concluded that AQP1 does not provide the route
for alveolar ﬂuid absorption and little effect was observed on Pf in the
AQP4 knockout studies [122]. A year later, the same group conducted
a very similar study, this time using AQP5 knockout mice; the
airspace-capillary Pf was reduced by 10-fold in the AQP5 knockout
and a further 2–3-fold when a double knockout of AQP1/AQP5 was
used. The authors concluded that AQP5 and AQP1 are the main routes
for transcellular water ﬂow in the airway with the primary role ofAQP5 being water transport across the apical plasma membrane of
type I alveolar epithelial cells [123].
TRPV4 was subsequently shown to regulate AQP5 abundance under
hypotonic conditions in mouse lung epithelial (MLE) cells [124]. After
2 h in hypotonic medium, a decrease in AQP5 abundance in MLE cells
was observed; this result was observable after 30 min but not before
10min exposure. This decline in AQP5 was blocked in the presence of
ruthenium red, which is a TRPV4 inhibitor, and also when the cells
were cultured in Ca2+-free medium, even when the osmolality was
reduced to 127mOsM (which is hypotonic); these data support a role
for extracellular Ca2+ in the regulation of AQP5 abundance. RT-PCR
results showed that mRNA levels were not affected when protein levels
decreased. When a lysosomal inhibitor was added, a reduction in AQP5
mRNA levels was not seen suggesting that AQP5 protein is probably
undergoing degradation. The same results were observed in TRPV4-
expressing and control HEK-293 cells transfected with AQP5; an AQP5
reduction in response to hypotonicity was only seen in cells expressing
TRPV4, which was also blocked by ruthenium red. The regulation of
membrane permeability byAQP5 abundancewas concluded to be tight-
ly controlled by osmolality and mediated by TRPV4 [124].
Further evidence that osmolality regulates AQP5 expression was
provided by Hoffert and colleagues [125], who showed that hypertonic
stress induces AQP5 expression in MLE cells cultured in hypertonic
medium (500 mOsM). AQP5 protein levels increased after 8 h and
peaked 24 h post-exposure, returning to baseline after 6 h in isotonic
medium. Only relatively impermeable solutes affected AQP5 expres-
sion, suggesting that an osmotic gradient between a cell and its environ-
ment is involved in the regulation of AQP5 expression. This expression
mechanism was demonstrated to require the activation of the extra-
cellular signal-regulated kinase (ERK) pathway since several ERK
inhibitors blocked AQP5 expression; however without a hypertonic
stimulus, AQP5 expression was inhibited and ERK activators failed to
induce expression. In the same study, rats that had been given daily
intraperitoneal injections of hypertonic saline had a 2-fold increase in
AQP5 expression in the lung compared with control rats, suggesting
the physiological relevance of AQP5 regulation mechanisms in vivo
[125].
AQP5 expression has also been shown to be regulated by a cyclic
AMP/protein kinase A (cAMP/PKA)-dependent pathway. In MLE cells,
addition of the cell-permeable cAMP analogue, cpt-cAMP, caused a 4-
fold increase in AQP5 mRNA and protein levels in a dose-dependent
manner; increased protein synthesis was ablated by the addition of
the PKA inhibitor, H89. Immunoﬂuorescence studies using confocal
microscopy on MLE cells after a 24 h cpt-cAMP treatment revealed
that AQP5 was translocated to the apical plasma membrane. Increasing
endogenous cAMP levels by treatment with forskolin and the β-
adrenergic agonist, isoproterenol, also induced AQP5 protein expres-
sion. The forskolin effect was also seen to work ex vivo in murine lung
tissue suggesting that this cAMP-dependent molecular mechanism
may occur in vivo [126].
Sidhaye and colleagues [127] looked at the effects of cAMP on the
regulation of AQP5 distribution and abundance. Using AQP5-
expressing mouse lung epithelial cells, the distribution of AQP5 was
observed by immunoﬂuorescence and surface biotinylation. After
short-term treatment of cells with cAMP, AQP5 was internalised and
there was a reduced abundance of AQP5 at the membrane; long term
exposure to cAMP (approximately 8 h) resulted in higher-than-
baseline AQP5 abundance at the apical membrane indicating an up-
regulation of AQP5 membrane expression. Following short-term
exposure, AQP5 abundance was also temporarily decreased followed
by a marked increase after an 8 h exposure. When cells were treated
with theβ-adrenergic agonist, tetrabutaline,which is known to increase
intracellular levels of cAMP, identical results to those observed after
cAMP addition were seen in terms of distribution and protein abun-
dance. The same effects were observed in vivo using mice injected
subcutaneously with the agonist. When the PKA inhibitor, H89, was
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AQP5 was phosphorylated by PKA but not PKC or casein, indicating that
PKA activation is required for AQP5 regulation in the airways.
Contrasting results were obtained from a study in which human
bronchial epithelial cells were stably transfected with wild type (WT)
AQP5 and two AQP5 mutants [128]. The ﬁrst mutant was an alanine
substitution of Ser156, the PKA substrate site for phosphorylation of
both AQP2 and AQP5, which is involved in AQP2 apical membrane
translocation. The second mutation was within the second Asn-Pro-
Ala motif, which forms the AQP pore. These experiments were designed
to examine the importance of pore formation and PKA phosphorylation
on the membrane expression of AQP5. WT-AQP5 was shown to be
expressed at the apical plasma membrane and in sub-apical vesicles,
while the Ser156Ala mutant also showed membrane expression. This
indicated that blocking the PKAbinding site did not affect AQP5 translo-
cation as in the case of AQP2. Expression of an Asn185Asp mutant was
localised throughout the cytoplasm suggesting that like AQP1, AQP5
requires the Asn-Pro-Ala motif for correct channel formation and that
it may have a role in either protein folding or oligomerisation. When
the PKA inhibitor, H89,was used, nodifference inmembrane expression
compared to the basal level was seen after 30min, which was also the
case after a 30min cAMP treatment in all three stable cell types. AQP2
translocation to the apical membrane was induced by the addition of
cAMP and this was blocked by pre-treatment with H89. Also when the
AQP2 Ser156 was mutated, AQP2 was expressed within the cytoplasm
and unable to translocate to the membrane. In WT-AQP5 and
Asn185Asp mutant cells, phosphorylation was seen before the addition
of cAMP. However, in the Ser156Ala mutant cells, AQP5 was never
phosphorylated indicating that Ser156 is the PKA substrate in AQP5,
that membrane localisation of the protein is not regulated by PKA and
that cAMP stimulation may be a separate event in contrast to the
AQP2 mechanism and the previous studies conducted by other groups
[128].
3.6.3. Conclusions
Direct evidence has been published for the involvement of AQPs in
transcellular water ﬂow across the alveolar epithelium via an apical
AQP5 route and through AQP1 in the endothelia [118]. This movement
of water between the alveolar airspace and capillary compartments is
essential for airway hydration, effective airways defences and
reabsorption of excess alveolar ﬂuid.
3.7. The reproductive system
The permeability of cell membranes to water and hormones in both
themale and female reproductive systems is essential for folliculogenesis
[2], spermatogenesis [129] and sperm osmoadaptation [41]. There are
few studies on the regulation of AQPs in the reproductive system, but
expression proﬁles have been outlined and up-to-date reviews are
available [41,129,130]. Emerging evidence suggests physiological roles
for AQPs within human reproductive systems and that water shifts are
often transcellular and AQP mediated [2]; AQPs have recently been
associated with the pathogenesis of some reproductive disorders such
as polycystic ovary syndrome (PCOS) [131] and ovarian cancer, where
AQP5 and AQP9 up-regulation were observed within the tissue of
malignant ovarian tumours [130].
3.7.1. The female reproductive system
The role of AQPs in the ovary, speciﬁcally the ovarian follicle, has
been well studied. During folliculogenesis, the antrum is expanded by
a large, rapid inﬂux of water through the granulosa cell (GC) lining; it
is unknown whether this water transport is mediated by paracellular
mechanisms or by transcellular ﬂow through AQP channels. McConnell
and colleagues [2] demonstrated that water movement into the antrum
of isolated rat follicles was 3.5-fold greater than that of C-inulin
(a complex sugar that moves through tissues via paracellular transfer),indicating that the inﬂux of water into the antral cavity has a transcellu-
lar component. When follicles were pre-treated with HgCl2 (an AQP
inhibitor), the movement of water was reduced to that of inulin. This
suggested a role for AQPs in mediating water movement during
folliculogenesis, especially in light of the detection of AQP7, AQP8 and
AQP9 in GCs by ﬂow cytometry [2]. AQP7 and AQP9 are aquaglyceropo-
rins; their presence within the ovarian follicle suggests that the ability
of small neutral solutes to be transported rapidly across the plasma
membrane may be a requirement of folliculogenesis.
In a recent study in women with PCOS, immunoﬂuorescence was
used to conﬁrm the presence of AQP9 in the nucleus, cytoplasm and
plasma membrane of human GCs. In a study of 14 PCOS sufferers and
31 control subjects who were infertile from tubal blockage, GCs and
follicular ﬂuid were collected from the participants. Total testosterone
(TT) and luteinising hormone (LH) levels were elevated in follicular
ﬂuid from PCOS compared with samples from control women; sex
hormone binding globulin (SHBG) levels were lower in PCOS patients.
RT-PCR results indicated that AQP9 mRNA levels were decreased in
PCOS sufferers and that there was a signiﬁcant correlation between
AQP9 mRNA and TT, LH and SHBG levels in PCOS samples, but no
correlations in control samples. In vitro studies showed that the
treatment of GCs with dihydrotestosterone (DHT) had an inhibitory
effect on AQP9 mRNA expression and that the addition of LY294002, a
phosphatidylinositol 3-kinase (PIK3) inhibitor, attenuated this down-
regulation such that AQP9 mRNA levels were raised compared with
those treated with DHT alone. The addition of H89 and forskolin
did not rectify the DHT-initiated AQP9 mRNA decrease suggesting
that PKA and cAMP pathways are not involved in this mechanism.
This suggests that hyperandrogenism (excess of androgenic hor-
mones) of the follicular ﬂuid occurs in PCOS and this suppresses
AQP9 expression in GCs through a PIK3 pathway affecting follicular
development [131]. Further work into the mechanisms behind
AQP9 regulation in healthy and pathogenic ovaries may provide in-
sight into possible treatments for diseases where hyperandrogenism
is an issue.
The data discussed above suggest that transcellular water ﬂow into
the antrum of the ovarian follicle is a key aspect of folliculogenesis
and that the movement of water for expansion of the antrum is likely
to be AQP mediated.3.7.2. The male reproductive system
There is increasing evidence that AQPs play an important role in
sperm cell RVD; this ensures maintenance of the structure and function
of sperm and thus male fertility. AQP7 cDNA was ﬁrst isolated from rat
testis and was shown to be expressed abundantly throughout the testis
and in the plasmamembrane of late stage spermatoids [132]. Aquaglyc-
eroporins, AQP3 and AQP7, have been identiﬁed within human sperm
[40,41,42,131,132,133] and their roles investigated. AQP3 has been de-
scribed as the regulator of spermosmoadaptation duringmale to female
transition, during which sperm are exposed to a hypo-osmotic environ-
ment with the potential to harm the sperm by excess swelling and re-
duced motility [41]. AQP3 is located at the plasma membrane of the
sperm ﬂagellum; AQP3mutant cells show decreasedmotility, increased
swelling and tail bending after entering the hypotonic environment of
the uterus therefore hindering the sperm's chances of reaching the ovi-
duct andmediating a fertilisation event. These defects are probably due
to ineffective RVDmechanisms and consequent swelling after hypoton-
ic stress [42]. A more recent study has outlined a relationship between
AQP7 localisation and sperm characteristics; transmission electron mi-
croscopy images showed expression of AQP7 within the pericentriolar
region of the neck, equatorial region of the acrosome and a diffuse stain-
ing along the tail. Abnormal sperm samples, characterised by malfor-
mations of the head, midpiece, or tail, displayed lower intensity and
diffuse staining in the cytoplasmic residual bodies, head and tail. A spe-
ciﬁc correlation between normal sperm AQP7 labelling and sperm
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tion of sperm cells and male fertility [134].
Severalmembers of the AQP family are expressedwithin the epidid-
ymis of the male reproductive tract [129]. They are localised to the
epithelial layer and are thought to play an important role in trans-
epithelial water transport and sperm concentration [129]. AQP9 was
the ﬁrst AQP identiﬁed in the epididymis [135] and has been labelled
the major apical AQP of the epithelium principal cells; it allows
transepithelial ﬂow of solutes such as glycerol, urea, mannitol and
sorbitol and is modulated by androgens in male adult rats [136]. AQP3
is localised exclusively to the basal cell membranes of the epididymis
and although AQP1 is absent from the epididymis epithelial cells it is
expressed within the smooth muscle and endothelium of the vascular
channels throughout the epididymis [137], together with AQP10 [138].
AQPs are important in facilitating an RVD response in sperm cells
especially upon the introduction to the hypotonic environment of the
female reproductive tract, which in AQP3-deﬁcient sperm can cause
detrimental swelling and reduced mobility. If the regulation of sperm
cells is dependent upon RVD mechanisms, future work into this ﬁeld
should concentrate on elucidating thesemechanisms. RVDmechanisms
in other tissues often involve complexes with AQPs, such as the
AQP4/TRPV4 complex in astrocytes [60] and the AQP2/TM5b interac-
tion in the kidney [77]. It is therefore feasible that AQP3 and/or AQP7
in human sperm might form molecular complexes with ion channels
such as the volume sensitive chloride channel CLC-3, which has been
identiﬁed in mammalian sperm and implicated in RVD [139,140].
3.8. The digestive system
3.8.1. Localisation and regulatory roles of AQPs
Secretion and absorption, two of the main functions of the digestive
system, both require the transfer of ﬂuid across cellular membranes.
Daily secretions in the form of saliva, gastric juices, intestinal mucous,
bile and pancreatic juice comprise a total volume of approximately
7.5 L of ﬂuid in the human digestive system; approximately 9 L of ﬂuid
is absorbed daily [141]. Several members of the AQP family are
expressed throughout the digestive system including AQP1 in the apical
and basolateral membranes and the cytoplasm of cholangiocytes, the
pancreas and throughout the endothelial cells of capillaries responsible
for transendothelial water transfer [142]; the epithelial lining of the
gastrointestinal tract contains AQP3 [143] and AQP4 [144,145]. Pancre-
atic duct cells express AQP8 in the apical plasma membrane [146] and
AQP8 [147] and AQP9 [148] are found in the hepatocytes of the liver;
in-depth reviews on the expression and localisation of AQPs in the
digestive system are available elsewhere [141,149].
In the upper digestive tract, AQP3 is expressed abundantly in strati-
ﬁed epithelia of the oral cavity to the fore-stomach. AQP3 is localised in
the basal and intermediate cell membrane becoming less abundant
towards the epithelial surface and is thought to provide a supply of
water from the sub-epithelial side of these cells which face harsh condi-
tions, such as the lowpHof the stomach, to prevent them fromdehydra-
tion [143]. Immunocytochemistry has shown strong AQP4 expression at
the basolateral membrane of the gastric parietal cells in mice and
was hypothesised to play a role in gastric acid secretion. Wang and
colleagues [144] used several secretory agonists to increase gastric
acid output in AQP4 null and control mice; no signiﬁcant differences
were seen in secretion levels suggesting that the deletion of AQP4 did
not affect the stomach's ability to secrete gastric acid [144].
In the distal colon and rectum, AQP3 is localised on the basolateral
membrane of the epithelial cells lining the lumen [143]. Inhibition of
AQP3 by HgCl2 in rats induced severe diarrhoea, suggesting a role for
AQP3 in regulating faecal water content [150], although it should be
noted that mercury is a toxic, non-speciﬁc inhibitor of AQP3 [151].
AQP3 may mediate the reabsorption of water from faeces by
transporting it from the lumen, across the endothelial layer into the
blood vessels via AQP1 [113]. The mechanism by which this iscontrolled is unknown but further understanding could lead to
treatments for over- or under-active bowel problems. For example,
the temporary inhibition of AQP3 could have a laxative effect.
AQP8 may have a role in bile secretion in hepatocytes, which are
responsible for the formation of bile before it is secreted into the bile
duct and modiﬁed by cholangiocytes. AQP8 was detected in the
cytoplasm and intracellular vesicles of rat hepatocytes by confocal
microscopy. Short-term treatment with cAMP induced re-distribution
of AQP8 to the plasmamembrane and an increase inwater permeability
within 10min. Themicrotubule inhibitor, colchicine, blocked the effects
of the cAMP treatment indicating that AQP8 translocation is stimulated
by cAMP and is microtubule dependent [152].3.8.2. Conclusions
The digestive system is a major site of ﬂuid movement and has a
wide AQP expression proﬁle within its organ network. A polarised
AQP expression pattern suggests that an organised transcellular route
for water is an essential role of AQPs in facilitating high secretion and
absorption rates.3.9. The musculoskeletal system
3.9.1. Localisation and regulatory roles of AQPs
Articular cartilage and intervertebral disc (IVD) tissue are specialised
biomechanical structures that are under constant compressive loads
[153,154]. The cells within these avascular tissues are exposed to con-
stantly harsh conditions as the IVD is ~80% water [155] and articular
cartilage tissue is around ~70% water [156]. The IVD is composed of
three distinct regions: the gelatinous nucleus pulposus (NP), which is
encapsulated by the annulus ﬁbrosus and the cartilaginous end
plates [153]. The native cells of the NP and cartilage tissue both secrete
proteoglycans and type II collagen; the collagen meshwork traps
negatively-charged proteoglycans (such as aggrecan) which attract
cations (mainly K+, Na+ and Ca+) resulting in the inﬂux of water; this
process is responsible for the high osmotic potential of these tissues
[157,158] enabling them to resist static and dynamic biomechanical
loads [154]. Both the NP cells and the chondrocytes must regulate
their volume and water content in these rapidly changing osmotic
environments; however little is known about the mechanisms which
they employ to do this. Recently, studies have taken place to identify
which AQPs are expressed in these tissues; AQP1 and low levels of
AQP3 have also been identiﬁed within the NP cells of the human IVD
[159] while AQP1 and AQP3 have been shown to be expressed and co-
localised at the membrane of equine articular cartilage chondrocyte
cells [154] and chondrocytes of the human knee [156].
AQP1 and AQP4 are expressed in skeletal muscle and a study has
shown that cell volume changes that occur during muscle contraction
rely on rapid water inﬂux [160]. AQP1 was found in the endothelial
cells of capillaries within the muscle tissue and AQP4 on the plasma
membrane of muscle ﬁbre cells [160]. The localisation of AQP1 and
AQP4 within the muscle tissue suggests a pathway for transcellular
water ﬂow through the endothelial cell membrane and the sarcolem-
ma; these AQPs may function together as transporters for water
between the blood and myoﬁbrils during mechanical muscle activity.3.9.2. Conclusions
It is not surprising that the native cells of the NP and articular
cartilage express AQPs and it is highly likely that AQPs are responsible
for CVR in these highly osmotic environments. More work is required
to elucidate the functional roles of aquaporins in these tissues; a
number of published studies have suggested roles for AQPs as compo-
nents of the vital cellular apparatus for maintenance of physiological
homeostasis of the musculoskeletal system.
1503R.E. Day et al. / Biochimica et Biophysica Acta 1840 (2014) 1492–15064. Conclusions
The constitutive distribution of AQPs is achieved by AQP gene
expression and/or AQP protein degradation on a timescale from hours
to days [161]. Further rapid spatial and temporal distribution of AQPs is
regulated by stimulated or triggered translocation of AQP-containing
vesicles to and from a particular membrane. This is particularly well
studied for V2R-mediated AQP2 translocation in kidney collecting duct
cells [74] (Fig. 3B). Similar mechanisms of triggered translocation have
been demonstrated for other AQPs [57]. We propose that the resulting
spatial and temporal distribution of AQPs is crucial for the regulation of
transcellular water ﬂow in the major systems of the human body.
For example, reabsorption of water from the lumen of the kidney
collecting duct involves transcellular water ﬂow mediated by AQP2 at
the apical membrane and AQP3 and AQP4 at the basolateral membrane.
Transcellular water ﬂow through endothelial cells of the capillary into
the blood is then mediated by AQP1 (Fig. 3A). In another example,
AQP4 knockout mice show near normal levels of intracranial pressure
and water content but reduced accumulation of water in the brain
following cytotoxic oedema caused by ischemic stroke, cerebral injury
and meningitis [162,163]. In vasogenic oedema mouse models, AQP4
null mice show greater water accumulation in the brain [61]. These
studies suggest that water homeostasis in a non-pathological state
may be independent of AQP4-mediated transcellular water ﬂow but
that AQP4 regulates transcellular water ﬂow in cerebral oedema
(Fig. 3C). In vasogenic oedema, water is eliminated from the extracellu-
lar space through AQP4 into the intact astrocytes that make up the BBB.
Water then exits the astrocyte through AQP4 in themembrane of astro-
cytic foot processes that surround the capillary. Transcellularwaterﬂow
through endothelial capillary cells into the blood is mediated by AQP1.
However, in cytotoxic oedema, transcellular water ﬂow from the
blood into astrocytes is mediated by AQP4.
In conclusion, it appears that AQPs are crucial for the regulation of
water homeostasis, providing selective pores for the rapid movement
of water, and other uncharged solutes, across diverse cell membranes
and playing regulatory roles in CVR. Gating mechanisms, which allow
conformationally distinct open and closed states, have been proposed
for human AQPs through molecular dynamic simulations [164], but
have only been speciﬁcally reported for plant and microbial AQPs
[165]. Consequently, it is likely that the distribution and abundance of
AQPs in a particular membrane are the determinants of membrane
water permeability and a regulator of transcellular water ﬂow.
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